Our Mission

Our mission is to prevent cardiovascular disease using AI-driven early warning and real-time monitoring, enabling earlier risk detection and a transition from reactive treatment to proactive, affordable care.

Our Guiding Principles

The foundation behind every decision we make.

Proactive Care Monitoring Wherever You Are.
AI-Driven Early Warning Detecting Cardiac Risk Sooner
Real Time Display Visibility For Peace Of Mind

Our Vision

To redefine cardiovascular care, setting continuous monitoring, early warning, and personalized prevention as the global standard—

creating a smart health platform that advances medical innovation and makes reliable heart health accessible to all.

Our Milestones

← PREV NEXT →
2016
  • Company Established
2019
  • NMPA (CFDA) Certification Achieved
2022
  • TFDA Certification Achieved
2025
  • New headquarter set up atTai Yuen Hi-Tech Industrial Park
  • FDA 510K K243003
  • ISO1348
2026
  • Obtain FDA SaMD approval
  • Obtain medical regulatory approvals in ASEAN, South America, and Middle Eastern countries.
  • Apply for MDA

Taiwan Headquarters

6F-1, No. 12, Taiyuan 2nd St., Zhubei City, Hsinchu County, Taiwan

Phone: +886 3 668 2091

Email: sales@vsigntek.com

US Branch Office 

46540 Fremont Blvd Ste 514, Fremont, CA 94538

Phone: +1 (510) 490-7899

Email: sales@vitalsignscorp.com

Powered by VitalSigns Technology All Rights Reserved.